Fulcrum therapeutics® to participate at the upcoming stifel 2022 biotech summer summit

Cambridge, mass., aug. 16, 2022 (globe newswire) -- fulcrum therapeutics, inc.  (nasdaq: fulc), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that management will participate in a fireside chat at the stifel 2022 biotech summer summit, on wednesday, august 17, 2022 at 11:30 a.m. et.
FULC Ratings Summary
FULC Quant Ranking